Premium IOLs Help Propel Strong Q2 as Bausch + Lomb Reports Growth and Raises 2026 Guidance
VAUGHAN, Ontario—Global eye health company Bausch + Lomb Corporation (NYSE/TSX: BLCO) yesterday announced its second quarter 2026 financial results and updated its 2026 full-year guidance. Total reported revenue…





